Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.43 |
| ▸ | POLB | P06746 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.43 |
| ▸ | RECQL | P46063 | 2/20 | 0.43 |
| ▸ | BLM | P54132 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | BAZ1A | Q9NRL2 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.37 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL439393 | 0.85 | RXFP1 (0.74) | RXFP1TDP1L3MBTL1POLBALDH1A1 | |
| SCHEMBL3376178 | 0.80 | RXFP1 (0.37) | RXFP1TDP1L3MBTL1ALDH1A1KDM4E | |
| SCHEMBL5464327 | 0.80 | F2 (0.41) | RXFP1TDP1L3MBTL1ALDH1A1KDM4E | |
| SCHEMBL219147 | 0.79 | KDM4E (0.66) | RXFP1TDP1L3MBTL1POLBALDH1A1 | |
| SCHEMBL17084525 | 0.79 | RXFP1 (0.67) | RXFP1TDP1L3MBTL1POLBALDH1A1 | |
| SCHEMBL19602 | 0.79 | SMN1; SMN2 (0.60) | TDP1L3MBTL1POLBALDH1A1KDM4E | |
| SCHEMBL3911427 | 0.78 | TDP1 (0.54) | RXFP1TDP1L3MBTL1POLBALDH1A1 | |
| SCHEMBL124216 | 0.78 | RXFP1 (0.65) | RXFP1TDP1L3MBTL1POLBALDH1A1 | |
| SCHEMBL959539 | 0.78 | RXFP1 (0.65) | RXFP1TDP1L3MBTL1POLBALDH1A1 | |
| SCHEMBL9078037 | 0.77 | RXFP1 (0.59) | RXFP1TDP1ALDH1A1RECQLHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2915186-B1 | FORMULATIONS OF SOLUTIONS AND PROCESSES FOR FORMING A SUBSTRATE INCLUDING AN ARSENIC DOPANT | VERSUM MAT US LLC (US) | 2020-10-28 | — | — | EP | claimed |
| CN-101516896-B | Phosphate ester compound, metal salt thereof, dental material, and demtal composition | MITSU CHEMICALS INC | 2013-06-05 | — | — | CN | claimed |
| CN-101516896-A | Phosphate ester compound, metal salt thereof, dental material, and demtal composition | MITSUI CHEMICALS INC (JP) | 2009-08-26 | — | — | CN | claimed |
| JP-8134077-A | — | — | None | — | — | JP | disclosed |
| EP-2915186-B1 | FORMULATIONS OF SOLUTIONS AND PROCESSES FOR FORMING A SUBSTRATE INCLUDING AN ARSENIC DOPANT | VERSUM MAT US LLC (US) | 2020-10-28 | — | — | EP | disclosed |
| CN-110194877-A | A kind of Nanometer composite hydrogel and its preparation method and application | 湘潭大学 | 2019-09-03 | — | — | CN | disclosed |
| CN-104781909-B | It is used to form the solution formula and method of the substrate comprising arsenic dopant | 慧盛材料美国有限责任公司 | 2019-02-05 | — | — | CN | disclosed |
| CN-109082126-A | A kind of hydrogel multi-stage motor and preparation method thereof of glucose responding driving | 华南理工大学 | 2018-12-25 | — | — | CN | disclosed |
| US-9867884-B2 | Vascular delivery systems | BEN-GURION UNIVERSITY OF NEGEV RESEARCH & DEVELOPMENT AUTHORITY (IL) | 2018-01-16 | — | — | US | disclosed |
| EP-2274017-B1 | E-SELECTIN SPECIFIC VASCULAR DELIVERY SYSTEMS | UNIV BEN GURION (IL) | 2016-04-13 | — | — | EP | disclosed |
| EP-2915186-A2 | FORMULATIONS OF SOLUTIONS AND PROCESSES FOR FORMING A SUBSTRATE INCLUDING AN ARSENIC DOPANT | Dynaloy, LLC (US) | 2015-09-09 | — | — | EP | disclosed |
| WO-2014071352-A2 | FORMULATIONS OF SOLUTIONS AND PROCESSES FOR FORMING A SUBSTRATE INCLUDING AN ARSENIC DOPANT | DYNALOY, LLC (US) | 2014-05-08 | — | — | WO | disclosed |
| US-20140124896-A1 | FORMULATIONS OF SOLUTIONS AND PROCESSES FOR FORMING A SUBSTRATE INCLUDING AN ARSENIC DOPANT | DYNALOY, LLC (US) | 2014-05-08 | — | — | US | disclosed |
| CN-101516896-B | Phosphate ester compound, metal salt thereof, dental material, and demtal composition | MITSU CHEMICALS INC | 2013-06-05 | — | — | CN | disclosed |
| EP-2510023-A1 | PHOTOALIGNMENT MATERIALS HAVING IMPROVED ADHESION | Transitions Optical, Inc. (US) | 2012-10-17 | — | — | EP | disclosed |
| US-20120014904-A1 | VASCULAR DELIVERY SYSTEMS | BEN-GURION UNIVERSITY OF THE NEGEV RESEARCH AND DEVELOPMENT AUTHORITY (IL) | 2012-01-19 | — | — | US | disclosed |
| WO-2011071794-A1 | PHOTOALIGNMENT MATERIALS HAVING IMPROVED ADHESION | TRANSITIONS OPTICAL, INC. (US) | 2011-06-16 | — | — | WO | disclosed |
| CN-101516896-A | Phosphate ester compound, metal salt thereof, dental material, and demtal composition | MITSUI CHEMICALS INC (JP) | 2009-08-26 | — | — | CN | disclosed |
| CN-1790772-A | Patterned substrate, electro-optical device, and method for manufacturing an electro-optical device | SEIKO EPSON CORP (JP) | 2006-06-21 | — | — | CN | disclosed |
| JP-H08134077-A | ANTIBACTERIAL MONOMER AND ITS SYNTHESIS | SOGO SHIKA IRYO KENKYUSHO:KK | 1996-05-28 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140124896-A1 | FORMULATIONS OF SOLUTIONS AND PROCESSES FOR FORMING A SUBSTRATE INCLUDING AN ARSENIC DOPANT | AS3MT, ABL1, ASF1A | RXFP1 3652/4885TDP1 209/4885L3MBTL1 1558/4885 |
| US-20120014904-A1 | VASCULAR DELIVERY SYSTEMS | SELE, SELPLG, SELL | RXFP1 2569/4885TDP1 2875/4885L3MBTL1 1609/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.